Modi Naturals Limited Stock Analysis

Q3 consolidated scale was strong, with revenue from operations of Rs 66,291.28 lakhs and total income of Rs 66,412.02 lakhs. / Profitability remained positive: EBITDA of Rs 5,761.38 lakhs, EBIT of Rs 5,386.88 lakhs, and PAT of Rs 3,061.00 lakhs in the quarter. / Margins were healthy for the quarter, with EBITDA margin at 8.68%, operating margin at 8.12%, and net profit margin at 4.61%. / Reported earnings were largely recurring in nature, with exceptional items at 0 and limited dependence on other income (Rs 120.74 lakhs). / Subsidiary Modi Biotech contributed meaningfully (Rs 8,118.71 lakhs revenue and Rs 892.05 lakhs net profit), and generated additional cash flow of Rs 477.98 lakhs via GST credit set-off.

Core cash-flow quality cannot be fully validated because operating cash flow, free cash flow, financing cash flow, investing cash flow, and capex data are not provided. / Raw-material intensity is high: cost of materials consumed was Rs 50,367.80 lakhs out of total expenses of Rs 61,025.14 lakhs, exposing margins to commodity volatility. / Finance costs were sizable at Rs 1,228.92 lakhs, and interest coverage of 4.38 suggests only moderate cushion if earnings soften. / Growth momentum is hard to confirm because YoY/QoQ revenue growth fields are not available, limiting trajectory assessment. / Regulatory uncertainty remains around newly notified Labour Codes; management said impact is currently not material but final rules are still pending.

Strong absolute profitability with consolidated PAT of Rs 3,061 lakhs and healthy EPS of Rs 7.58 for Q3 FY2025-26, indicating solid earnings generation capability / Diversified revenue base with Branded segment contributing Rs 13,266.02 lakhs and Bulk segment Rs 9,825.72 lakhs, reducing dependence on any single business line / Adequate interest coverage ratio of 4.38x demonstrates comfortable debt servicing ability relative to operating profits / Subsidiary Modi Biotech Private Limited contributed meaningfully with revenues of Rs 8,118.71 lakhs and net profit of Rs 892.05 lakhs, representing strong group-level performance / Tax optimization through GST credit management generated additional cash flow of Rs 477.98 lakhs during the quarter, showcasing operational efficiency / EBITDA margin of 8.68% and operating margin of 8.12% indicate reasonably profitable operations in the FMCG and commodity business context

Complete absence of cash flow statement data prevents assessment of operating cash generation, free cash flow, and actual liquidity position despite visible finance costs of Rs 1,228.92 lakhs / No year-over-year or quarter-over-quarter revenue growth metrics provided, making it impossible to evaluate business momentum or market share trajectory / Missing critical balance sheet details including debt levels, working capital, current ratio, and debt-to-equity ratio create uncertainty about financial leverage and short-term solvency / Regulatory uncertainty from newly notified Labour Codes (Code on Wages 2019, Industrial Relations Code 2020, Code on Social Security 2020) with impact assessment pending complete rule notifications / High cost of materials at Rs 50,367.80 lakhs (75.9% of total revenue) exposes the company to commodity price volatility and margin pressure risks / Limited disclosure on return ratios (ROE, ROA, ROCE all null) and asset efficiency metrics prevents evaluation of capital allocation effectiveness and return on invested capital